<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2025-14-4-2166</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-2229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕГУЛЯТОРНЫЕ ВОПРОСЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REGULATORY ISSUES</subject></subj-group></article-categories><title-group><article-title>Реализация принципов надлежащей исследовательской практики на примере системы менеджмента качества университета</article-title><trans-title-group xml:lang="en"><trans-title>Implementation of the good research practice principles using the example of the university quality management system</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0152-9841</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гиба</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Giba</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>354340, Краснодарский край, федеральная территория «Сириус», Олимпийский пр., д. 1</p></bio><bio xml:lang="en"><p>1, Olimpiyskiy prospect, 354340, federal territory "Sirius", Krasnodar region, 354340</p></bio><email xlink:type="simple">giba.is@talantiuspeh.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-2361-0583</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пронских</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Pronskikh</surname><given-names>A. Е.</given-names></name></name-alternatives><bio xml:lang="ru"><p>354340, Краснодарский край, федеральная территория «Сириус», Олимпийский пр., д. 1</p></bio><bio xml:lang="en"><p>1, Olimpiyskiy prospect, 354340, federal territory "Sirius", Krasnodar region, 354340</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-9106-0116</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минтель</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mintel</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>354340, Краснодарский край, федеральная территория «Сириус», Олимпийский пр., д. 1</p></bio><bio xml:lang="en"><p>1, Olimpiyskiy prospect, 354340, federal territory "Sirius", Krasnodar region, 354340</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-5528-150X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чувашов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuvashov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>354340, Краснодарский край, федеральная территория «Сириус», Олимпийский пр., д. 1</p></bio><bio xml:lang="en"><p>1, Olimpiyskiy prospect, 354340, federal territory "Sirius", Krasnodar region, 354340</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-технологический университет «Сириус»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sirius University of Science and Technology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2025</year></pub-date><volume>14</volume><issue>4</issue><fpage>295</fpage><lpage>306</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гиба И.С., Пронских А.Е., Минтель М.В., Чувашов А.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Гиба И.С., Пронских А.Е., Минтель М.В., Чувашов А.А.</copyright-holder><copyright-holder xml:lang="en">Giba I.S., Pronskikh A.Е., Mintel M.V., Chuvashov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/2229">https://www.pharmjournal.ru/jour/article/view/2229</self-uri><abstract><sec><title>Введение</title><p>Введение. Обеспечение качества исследовательских работ является ключевым фактором научных открытий, а также появления на рынке инновационных высокомаржинальных продуктов. В связи с особенностью научно-исследовательской деятельности единые правила по организации и проведению исследований, удовлетворяющие потребностям как научных групп, так и бизнеса, заинтересованного в коммерциализации разработок, в том числе разработок, связанных с лекарственными средствами, в данный момент отсутствуют, а индивидуальные подходы только формируются. Совокупность сложившихся подходов и концепций, согласно существующей системе надлежащих практик (GxP), получила название «Надлежащая исследовательская практика», или GRP.</p></sec><sec><title>Цель</title><p>Цель. Обобщение существующих мировых трендов в области надлежащей исследовательской практики и описание реализации принципов GRP на примере системы менеджмента качества лабораторного комплекса Университета «Сириус».</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Методы реализации принципов GRP в лабораторном комплексе базируются на требованиях ISO 9001 и рекомендациях ICH в таких областях, как управление документами и записями, управление персоналом и обучением, управление аудитами и инспекциями, управление рисками, анализ и оценка результативности и эффективности деятельности.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Проанализированы текущие принципы GRP, сформированные в рамках национальных научных сообществ, отдельных университетов и государственных программ. На базе лабораторного комплекса Университета «Сириус» рассмотрены возможности и примеры комплексной имплементации GRP в такие области системы менеджмента качества, как управление документами и записями, управление персоналом и обучением, управление аудитами и инспекциями, управление рисками, проведение периодического анализа и оценки результативности и эффективности деятельности.</p></sec><sec><title>Заключение</title><p>Заключение. Описанный в статье подход к проведению научно-исследовательских работ, основанный на комплексной имплементации GRP, является инструментом обеспечения качества исследований, необходимым как для сугубо научной деятельности, так и для успешного научно-прикладного взаимодействия между академической средой и фармацевтическими компаниями с целью ускорения вывода на рынок новых лекарственных средств и удовлетворения запроса пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The quality assurance of research work is a key factor in scientific discoveries, as well as the emergence of innovative high-margin products on the market. Due to the specific nature of the scientific research field, there are currently no uniform rules for organizing and conducting research that meet the needs of both scientific groups and businesses interested in the commercialization of developments, including drug developments, and individual approaches are only being formed. The set of established approaches and concepts, according to the existing system of good practices (GxP), is called "Good Research Practice" or GRP.</p></sec><sec><title>Аim</title><p>Аim. Generalization of existing global trends in the field of Good Research Practice and description of the implementation of GRP principles using the example of the quality management system of the Sirius University Laboratory Facility.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The methods of GRP principles implementation in the Laboratory Complex are based on the requirements of ISO 9001 and ICH recommendations in such areas as document and record management, personnel and training management, audit and inspection management, risk management, analysis and evaluation of performance and efficiency.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The current principles of GRP, formed within the framework of national scientific communities, individual universities and state programs, are analyzed. Using the example of the Laboratory Facility of the Sirius University, the possibilities and examples of complex implementation of GRP in such areas of the quality management system as document and record management, personnel and training management, audit and inspection management, risk management, conducting periodic analysis and assessment of the effectiveness and efficiency of activities are considered.</p></sec><sec><title>Conclusion</title><p>Conclusion. The approach to conducting scientific research work described in the article, based on the integrated implementation of GRP, is a tool for ensuring the quality of research, necessary both for purely scientific activities and for successful scientific and applied interaction between the academic environment and pharmaceutical companies in order to accelerate the launch of new drugs to the market and meet patient demand.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>надлежащая исследовательская практика</kwd><kwd>Good Research Practice (GRP)</kwd><kwd>целостность данных (data integrity)</kwd><kwd>ALCOA+</kwd><kwd>ISO 9001</kwd><kwd>система менеджмента качества</kwd><kwd>Good Documentation Practices (GDP)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Good Research Practice (GRP)</kwd><kwd>data integrity</kwd><kwd>ALCOA+</kwd><kwd>ISO 9001</kwd><kwd>quality management system</kwd><kwd>Good Documentation Practices (GDP)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lexchin J., Bero L. A., Djulbegovic B., Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167–1170. DOI: 10.1136/bmj.326.7400.1167.</mixed-citation><mixed-citation xml:lang="en">Lexchin J., Bero L. A., Djulbegovic B., Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167–1170. DOI: 10.1136/bmj.326.7400.1167.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gersdorf T., He V. F., Schlesinger A., Koch G., Ehrismann D., Widmer H., von Krogh G. Demystifying industry-academia collaboration. Nature Reviews Drug Discovery. 2019;18(10):743–744. DOI: 10.1038/d41573-019-00001-2.</mixed-citation><mixed-citation xml:lang="en">Gersdorf T., He V. F., Schlesinger A., Koch G., Ehrismann D., Widmer H., von Krogh G. Demystifying industry-academia collaboration. Nature Reviews Drug Discovery. 2019;18(10):743–744. DOI: 10.1038/d41573-019-00001-2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Titball R. W., Bernstein D. I., Fanget N. V. J., Hall R. A., Longet S., MacAry P. A., Rupp R. E., van Gils M., von Messling V., Walker D. H., Barrett A. D. T. Progress with COVID vaccine development and implementation. npj Vaccines. 2024;9:69. DOI: 10.1038/s41541-024-00867-3.</mixed-citation><mixed-citation xml:lang="en">Titball R. W., Bernstein D. I., Fanget N. V. J., Hall R. A., Longet S., MacAry P. A., Rupp R. E., van Gils M., von Messling V., Walker D. H., Barrett A. D. T. Progress with COVID vaccine development and implementation. npj Vaccines. 2024;9:69. DOI: 10.1038/s41541-024-00867-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lee P., Kim C.-U., Seo S. H., Kim D.-J. Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages. Immune Network. 2021;21(1):e4. DOI: 10.4110/in.2021.21.e4.</mixed-citation><mixed-citation xml:lang="en">Lee P., Kim C.-U., Seo S. H., Kim D.-J. Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages. Immune Network. 2021;21(1):e4. DOI: 10.4110/in.2021.21.e4.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Imran M., Arora M. K., Asdaq S. M. B., Khan S. A., Alaqel S. I., Alshammari M. K., Alshehri M. M., Alshrari A. S., Ali A. M., Al-shammeri A. M., Alhazmi B. D., Harshan A. A., Alam M. T., Abida A. Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19. Molecules. 2021;26(19):5795. DOI: 10.3390/molecules26195795.</mixed-citation><mixed-citation xml:lang="en">Imran M., Arora M. K., Asdaq S. M. B., Khan S. A., Alaqel S. I., Alshammari M. K., Alshehri M. M., Alshrari A. S., Ali A. M., Al-shammeri A. M., Alhazmi B. D., Harshan A. A., Alam M. T., Abida A. Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19. Molecules. 2021;26(19):5795. DOI: 10.3390/molecules26195795.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ma Z., Augustijn K., de Esch I. J. P., Bossink B. Collaborative university–industry R&amp;D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review. Drug Discovery Today. 2022;27(8):2333–2341. DOI: 10.1016/j.drudis.2022.05.001.</mixed-citation><mixed-citation xml:lang="en">Ma Z., Augustijn K., de Esch I. J. P., Bossink B. Collaborative university–industry R&amp;D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review. Drug Discovery Today. 2022;27(8):2333–2341. DOI: 10.1016/j.drudis.2022.05.001.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrins L., Pollastri M. P. The importance of collaboration between industry, academics, and nonprofits in tropical disease drug discovery. ACS Infectious Diseases. 2018;4(4):445–448. DOI: 10.1021/acsinfecdis.7b00208.</mixed-citation><mixed-citation xml:lang="en">Ferrins L., Pollastri M. P. The importance of collaboration between industry, academics, and nonprofits in tropical disease drug discovery. ACS Infectious Diseases. 2018;4(4):445–448. DOI: 10.1021/acsinfecdis.7b00208.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Melnychuk T., Schultz C., Wirsich A. The effects of university–industry collaboration in preclinical research on pharmaceutical firms’ R&amp;D performance: Absorptive capacity’s role. Journal of Product Innovation Management. 2021;38:355–378. DOI: 10.1111/jpim.12572.</mixed-citation><mixed-citation xml:lang="en">Melnychuk T., Schultz C., Wirsich A. The effects of university–industry collaboration in preclinical research on pharmaceutical firms’ R&amp;D performance: Absorptive capacity’s role. Journal of Product Innovation Management. 2021;38:355–378. DOI: 10.1111/jpim.12572.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Abramo G., D’Angelo C. A., Di Costa F., Solazzi M. The role of information asymmetry in the market for university-industry research collaboration. The Journal of Technology Transfer. 2011;36(1):84–100. DOI: 10.1007/s10961-009-9131-5.</mixed-citation><mixed-citation xml:lang="en">Abramo G., D’Angelo C. A., Di Costa F., Solazzi M. The role of information asymmetry in the market for university-industry research collaboration. The Journal of Technology Transfer. 2011;36(1):84–100. DOI: 10.1007/s10961-009-9131-5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">O’Dwyer M., Filieri R., O’Malley L. Establishing successful university–industry collaborations: barriers and enablers deconstructed. The Journal of Technology Transfer. 2023;48:900–931. DOI: 10.1007/s10961-022-09932-2.</mixed-citation><mixed-citation xml:lang="en">O’Dwyer M., Filieri R., O’Malley L. Establishing successful university–industry collaborations: barriers and enablers deconstructed. The Journal of Technology Transfer. 2023;48:900–931. DOI: 10.1007/s10961-022-09932-2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenblatt M. How academia and the pharmaceutical industry can work together: the president’s lecture, annual meeting of the American Thoracic Society, San Francisco, California. Annals of the American Thoracic Society. 2013;10(1):31–38. DOI: 10.1513/AnnalsATS.201209-075PS.</mixed-citation><mixed-citation xml:lang="en">Rosenblatt M. How academia and the pharmaceutical industry can work together: the president’s lecture, annual meeting of the American Thoracic Society, San Francisco, California. Annals of the American Thoracic Society. 2013;10(1):31–38. DOI: 10.1513/AnnalsATS.201209-075PS.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Scherer F. M. Research and development costs and productivity in biopharmaceuticals. In: Anthony J. Culyer, editor. Encyclopedia of Health Economics. Amsterdam: Elsevier; 2014. P. 249–255. DOI: 10.1016/B978-0-12-375678-7.01203-7.</mixed-citation><mixed-citation xml:lang="en">Scherer F. M. Research and development costs and productivity in biopharmaceuticals. In: Anthony J. Culyer, editor. Encyclopedia of Health Economics. Amsterdam: Elsevier; 2014. P. 249–255. DOI: 10.1016/B978-0-12-375678-7.01203-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шаброва Н. В., Амбарова П. А. Публикационная активность студентов российских вузов Образование и наука. 2023;25(9):171–196. DOI: 10.17853/1994-5639-2023-9-171-196.</mixed-citation><mixed-citation xml:lang="en">Shabrova N. V., Ambarova P. A. Publication activity of Russian university students. The Education and science journal. 2023;25(9):171–196. (In Russ.) DOI: 10.17853/1994-5639-2023-9-171-196.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Полихина Н. А. Публикационная активность научно-педагогических работников в России: результаты, тенденции, проблемы. Управление наукой и наукометрия. 2020;15(2):196–222. DOI: 10.33873/2686-6706.2020.15-2.196-222.</mixed-citation><mixed-citation xml:lang="en">Polikhina N. A. Publication activity of academic staff in Russia: results, trends, problems. Science Governance and Scientometrics. 2020;15(2):196–222. (In Russ.) DOI: 10.33873/2686-6706.2020.15-2.196-222.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Хрусталев М. Б., Турбина Н. Ю., Максимова А. А. Медицинские вузы России в международных рейтингах: сравнение наукометрических критериев. Ученые записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова. 2018;25(3):25–34. DOI: 10.24884/1607-4181-2018-25-3-25-34.</mixed-citation><mixed-citation xml:lang="en">Khrustalev M. B., Turbina N. Yu., Maksimova A. A. Russian medical universities in international rankings: comparison of scientometric criteria. The Scientific Notes of the Pavlov University. 2018;25(3):25–34. (In Russ.) DOI: 10.24884/1607-4181-2018-25-3-25-34.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Гуськов А. Е., Косяков Д., Селиванова И. В. Стратегии повышения публикационной активности университетов – участников Проекта 5-100. Научные и технические библиотеки. 2017;(12):5–18. DOI: 10.33186/1027-3689-2017-12-5-18.</mixed-citation><mixed-citation xml:lang="en">Guskov A., Kosyakov D., Selivanova I. Strategies to improve publication activities of the universities participating in Project 5-100. Scientific and Technical Libraries. 2017;(12):5–18 (In Russ.) DOI: 10.33186/1027-3689-2017-12-5-18.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Халадов Х.-А. С. Головина И. В., Папуткова Г. А. Публикационная активность педагогических вузов: количественные и качественные показатели. Высшее образование в России. 2022;31(2):58–67. DOI: 10.31992/0869-3617-2022-31-2-58-67.</mixed-citation><mixed-citation xml:lang="en">Khaladov Kh.-A. S., Golovina I. V., Paputkova G. A. Publication activity of pedagogical universities: quantitative and qualitative indicators. Higher Education in Russia. 2022;31(2):58–67. (In Russ.) DOI: 10.31992/0869-3617-2022-31-2-58-67.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shah F. A., Jawaid S. A. The h-index: An indicator of research and publication output. Pakistan Journal of Medical Sciences. 2023;39(2):315–316. DOI: 10.12669/pjms.39.2.7398.</mixed-citation><mixed-citation xml:lang="en">Shah F. A., Jawaid S. A. The h-index: An indicator of research and publication output. Pakistan Journal of Medical Sciences. 2023;39(2):315–316. DOI: 10.12669/pjms.39.2.7398.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Akhtar M. K. The h-index is an unreliable research metric for evaluating the publication impact of experimental scientists. Frontiers in Research Metrics and Analytics. 2024;9:1385080. DOI: 10.3389/frma.2024.1385080.</mixed-citation><mixed-citation xml:lang="en">Akhtar M. K. The h-index is an unreliable research metric for evaluating the publication impact of experimental scientists. Frontiers in Research Metrics and Analytics. 2024;9:1385080. DOI: 10.3389/frma.2024.1385080.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ofer D., Kaufman H., Linial M. What’s next? Forecasting scientific research trends. Heliyon. 2024;10(1):e23781. DOI: 10.1016/j.heliyon.2023.e23781.</mixed-citation><mixed-citation xml:lang="en">Ofer D., Kaufman H., Linial M. What’s next? Forecasting scientific research trends. Heliyon. 2024;10(1):e23781. DOI: 10.1016/j.heliyon.2023.e23781.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rantanen J., Khinast J. The future of pharmaceutical manufacturing sciences. Journal of Pharmaceutical Sciences. 2015;104(11):3612–3638. DOI: 10.1002/jps.24594.</mixed-citation><mixed-citation xml:lang="en">Rantanen J., Khinast J. The future of pharmaceutical manufacturing sciences. Journal of Pharmaceutical Sciences. 2015;104(11):3612–3638. DOI: 10.1002/jps.24594.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">McMurray C. A scientific fraud. An investigation. A lab in recovery. The Transmitter. 2024. DOI: 10.53053/USNX9479.</mixed-citation><mixed-citation xml:lang="en">McMurray C. A scientific fraud. An investigation. A lab in recovery. The Transmitter. 2024. DOI: 10.53053/USNX9479.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Khajuria A., Agha R. Fraud in scientific research – birth of the Concordat to uphold research integrity in the United Kingdom. Journal of the Royal Society of Medicine. 2014;107(2):61–65. DOI: 10.1177/0141076813511452.</mixed-citation><mixed-citation xml:lang="en">Khajuria A., Agha R. Fraud in scientific research – birth of the Concordat to uphold research integrity in the United Kingdom. Journal of the Royal Society of Medicine. 2014;107(2):61–65. DOI: 10.1177/0141076813511452.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wittau J., Seifert R. How to fight fake papers: a review on important information sources and steps towards solution of the problem. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2024;397:9281–9294. DOI: 10.1007/s00210-024-03272-8.</mixed-citation><mixed-citation xml:lang="en">Wittau J., Seifert R. How to fight fake papers: a review on important information sources and steps towards solution of the problem. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2024;397:9281–9294. DOI: 10.1007/s00210-024-03272-8.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Frederickson R. M., Herzog R. W. Addressing the big business of fake science. Molecular Therapy. 2022;30(7):2390. DOI: 10.1016/j.ymthe.2022.06.001.</mixed-citation><mixed-citation xml:lang="en">Frederickson R. M., Herzog R. W. Addressing the big business of fake science. Molecular Therapy. 2022;30(7):2390. DOI: 10.1016/j.ymthe.2022.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Montgomery Collins E., Bassat Q. The scientific integrity of journal publications in the age of "Fake News". Journal of Tropical Pediatrics. 2018;64(5):360–363. DOI: 10.1093/tropej/fmy039.</mixed-citation><mixed-citation xml:lang="en">Montgomery Collins E., Bassat Q. The scientific integrity of journal publications in the age of "Fake News". Journal of Tropical Pediatrics. 2018;64(5):360–363. DOI: 10.1093/tropej/fmy039.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Parker L., Boughton S., Lawrence R., Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. Journal of Clinical Epidemiology. 2022;151:1–17. DOI: 10.1016/j.jclinepi.2022.07.006.</mixed-citation><mixed-citation xml:lang="en">Parker L., Boughton S., Lawrence R., Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. Journal of Clinical Epidemiology. 2022;151:1–17. DOI: 10.1016/j.jclinepi.2022.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Sabel B. A., Knaack E., Gigerenzer G., Bilc M. Fake publications in biomedical science: red-flagging method indicates mass production. medRxiv. 2023. DOI: 10.1101/2023.05.06.23289563.</mixed-citation><mixed-citation xml:lang="en">Sabel B. A., Knaack E., Gigerenzer G., Bilc M. Fake publications in biomedical science: red-flagging method indicates mass production. medRxiv. 2023. DOI: 10.1101/2023.05.06.23289563.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bespalov A., Bernard R., Gilis A., Gerlach B., Guillén J., Castagné V., Lefevre I. A., Ducrey F., Monk L., Bongiovanni S., Altevogt B., Arroyo-Araujo M., Bikovski L., de Bruin N., Castaños-Vélez E., Dityatev A., Emmerich C. H., Fares R., Ferland-Beckham C., Froger-Colléaux C., Gailus-Durner V., Hölter S. M., Hofmann M. C. J., Kabitzke P., Kas M. J. H., Kurreck C., Moser P., Pietraszek M., Popik P., Potschka H., Montes de Oca E. P., Restivo L., Riedel G., Ritskes-Hoitinga M., Samardzic J., Schunn M., Stöger C., Voikar V., Vollert J., Wever K. E., Wuyts K., MacLeod M. R., Dirnagl U., Steckler T. Introduction to the EQIPD quality system. eLife. 2021;10:e63294. DOI: 10.7554/eLife.63294.</mixed-citation><mixed-citation xml:lang="en">Bespalov A., Bernard R., Gilis A., Gerlach B., Guillén J., Castagné V., Lefevre I. A., Ducrey F., Monk L., Bongiovanni S., Altevogt B., Arroyo-Araujo M., Bikovski L., de Bruin N., Castaños-Vélez E., Dityatev A., Emmerich C. H., Fares R., Ferland-Beckham C., Froger-Colléaux C., Gailus-Durner V., Hölter S. M., Hofmann M. C. J., Kabitzke P., Kas M. J. H., Kurreck C., Moser P., Pietraszek M., Popik P., Potschka H., Montes de Oca E. P., Restivo L., Riedel G., Ritskes-Hoitinga M., Samardzic J., Schunn M., Stöger C., Voikar V., Vollert J., Wever K. E., Wuyts K., MacLeod M. R., Dirnagl U., Steckler T. Introduction to the EQIPD quality system. eLife. 2021;10:e63294. DOI: 10.7554/eLife.63294.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Bespalov A., Michel M. C., Steckler T., editors. Good research practice in non-clinical pharmacology and biomedicine. Cham: SpringerOpen; 2020. 423 p. DOI: 10.1007/978-3-030-33656-1.</mixed-citation><mixed-citation xml:lang="en">Bespalov A., Michel M. C., Steckler T., editors. Good research practice in non-clinical pharmacology and biomedicine. Cham: SpringerOpen; 2020. 423 p. DOI: 10.1007/978-3-030-33656-1.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Colavizza G., Hrynaszkiewicz I., Staden I., Whitaker K., McGillivray B. The citation advantage of linking publications to research data. PLoS ONE. 2020;15(4):e0230416. DOI: 10.1371/journal.pone.0230416.</mixed-citation><mixed-citation xml:lang="en">Colavizza G., Hrynaszkiewicz I., Staden I., Whitaker K., McGillivray B. The citation advantage of linking publications to research data. PLoS ONE. 2020;15(4):e0230416. DOI: 10.1371/journal.pone.0230416.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Schwab S., Janiaud P., Dayan M., Amrhein V., Panczak R., Palagi P. M., Hemkens L. G., Ramon M., Rothen N., Senn S., Furrer E., Held L. Ten simple rules for good research practice. PLoS Computational Biology. 2022;18(6):e1010139. DOI: 10.1371/journal.pcbi.1010139.</mixed-citation><mixed-citation xml:lang="en">Schwab S., Janiaud P., Dayan M., Amrhein V., Panczak R., Palagi P. M., Hemkens L. G., Ramon M., Rothen N., Senn S., Furrer E., Held L. Ten simple rules for good research practice. PLoS Computational Biology. 2022;18(6):e1010139. DOI: 10.1371/journal.pcbi.1010139.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kavasidis I., Lallas E., Leligkou H. C., Oikonomidis G., Karydas D., Gerogiannis V. C., Karageorgos A. Deep transformers for computing and predicting ALCOA+ data integrity compliance in the pharmaceutical industry. Applied Sciences. 2023;13(13):7616. DOI: 10.3390/app13137616.</mixed-citation><mixed-citation xml:lang="en">Kavasidis I., Lallas E., Leligkou H. C., Oikonomidis G., Karydas D., Gerogiannis V. C., Karageorgos A. Deep transformers for computing and predicting ALCOA+ data integrity compliance in the pharmaceutical industry. Applied Sciences. 2023;13(13):7616. DOI: 10.3390/app13137616.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gokulakrishnan D., Venkataraman S. Ensuring data integrity: best practices and strategies in pharmaceutical industry. Intelligent Pharmacy. 2025:3(4):296–303. DOI: 10.1016/j.ipha.2024.09.010.</mixed-citation><mixed-citation xml:lang="en">Gokulakrishnan D., Venkataraman S. Ensuring data integrity: best practices and strategies in pharmaceutical industry. Intelligent Pharmacy. 2025:3(4):296–303. DOI: 10.1016/j.ipha.2024.09.010.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Mollah A. H., Long M., Baseman H. S., editors. Risk management applications in pharmaceutical and biopharmaceutical manufacturing. Hoboken: John Wiley &amp; Sons, Inc.; 2013. 432 p. DOI: 10.1002/9781118514399.</mixed-citation><mixed-citation xml:lang="en">Mollah A. H., Long M., Baseman H. S., editors. Risk management applications in pharmaceutical and biopharmaceutical manufacturing. Hoboken: John Wiley &amp; Sons, Inc.; 2013. 432 p. DOI: 10.1002/9781118514399.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sandle T. Risk management and risk assessment for pharmaceutical manufacturing: a contamination control perspective. London: CreateSpace; 2013. 168 p.</mixed-citation><mixed-citation xml:lang="en">Sandle T. Risk management and risk assessment for pharmaceutical manufacturing: a contamination control perspective. London: CreateSpace; 2013. 168 p.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
